In accordance with this results, analyses of tumour samples from lung cancer patients with EGFR mutations revealed a significant inverse correlation between MIG-6 expression their survival rates after the treatment with EGFR-TKI [159]. The gene discussed is EGFR; the disease is lung carcinoma.